SKAN AG, COMECER S.p.A. and Getinge AB are dominating the Global Pharmaceutical Isolator Market in 2018

Global pharmaceutical isolator market is expected to grow at a substantial CAGR of 7.7% in the forecast period of 2019 to 2026. The years considered for study are as mentioned below.

Access Full Report at https://databridgemarketresearch.com/reports/global-pharmaceutical-isolator-market/

The pharmaceutical isolator market is a highly concentrated market which includes key players and local players. The market has witnessed increased various strategic developments owing to favourable market scenario. The market has a prominent growth in upcoming years due to growing demand for the pharmaceutical isolators across booming pharmaceutical, low operational cost of pharmaceutical isolators, increasing regulations and cost of noncompliance and high maintenance of aseptic condition in the production of pharmaceutical products.

The market has witness developments in terms of merger and acquisitions, partnerships or product launches to enhance the product portfolio to meet the rising demand of innovative technology in the maintenance of aseptic processing of pharmaceutical products. For instance, In June 2018, Fedegari Autoclavi S.p.A has developed fully integrated robotized solutions for different customer. Integrated System will help customers to achieve best performances and cost-effectiveness. This product will expand the company profile and portfolio, since Fedegari Autoclavi S.p.A deals with pharmaceutical isolator. Such developments will only lead to a healthy future for pharmaceutical isolator market in aseptic injectable drugs processing.

SKAN AG dominated the pharmaceutical isolator market and accounts for the highest market share in 2018 which is followed by COMECER S.p.A, Getinge AB and Wabash National Corporation. The other key players existing in the market includes Chiyoda Corporation, Azbil Corporation, Germfree, MBRAUN, NuAire, ITECO s.r.l., Hosokawa, Hecht Technologie GmbH, Steriline S.r.l., Envair Limited, Vanrx Pharmasystems Inc., TEMA SINERGIE S.p.A , Bioquell Inc., I.M.A. INDUSTRIA MACCHINE AUTOMATICHE S.P.A., JACOMEX, Fedegari Autoclavi S.p.A among others.

SKAN AG:

SKAN AG headquartered in Allschwil, Switzerland was founded in 1968. The company is engaged in providing on field cleanroom equipment and isolator design for the global pharmaceutical industry. The company has six operating product categories Accessories, Isolator, LabEquipment, RABS, SKANFOG Products and Transfer System. The market focused category lies under isolator’s category. The company is continuously engaged in strategic relationship to enhance the production and manufacturing of the isolators.

  • In February 2018, SKAN AG announced that collaboration agreement with FARMA ALIMENTA (Spain). This collaboration will boost the position within the Spanish market making new contacts with companies and to work on new interesting projects.

It has its global networks through direct sales representatives and distributors in the North America, Europe, South America, Asia, Europe and Middle East & Africa. The company has various subsidiaries such as Aseptic Technologies (U.S.) and Hasler Maschinen- Apparatebau AG (Switzerland).

COMECER S.p.A.:

COMECER S.p.A. headquartered in Ravenna, Italy was founded in mid-1970s. The company is engaged in designing and manufacture high-technology systems in the field of pharma, radiopharma and regenerative medicine. The company has five operating product categories Radiopharma, Pharma, ATMP, Aseptic Food Processing and Aerospace & Semiconductor. Moreover, it is focuses on Radiopharma, Pharma and ATMP. The company provides pharmaceutical isolators for dispensing, weighing, sampling and other sterility testing, which is designed for the production units and pharmaceutical research and development laboratories.

  • In May 2018, COMECER S.p.A. announced the new agreement with the Advaxis, Inc (U.S.) for the production of aseptic systems for the manufacturing process and for the development of the immunotherapy. The new agreement between the companies forcing the R&D of the Comecer for isolation technology.

It has its global established offices are in Netherland, U.S., India, Taiwan and UAE, whereas company distribute their pharmaceutical isolator and other products worldwide. It operates through its subsidiaries such as Veenstra Instrumenten BV (Netherlands) and Brita Trade, s.r.o. (Czech Republic).

Getinge AB:

Getinge AB is headquartered in Gothenburg, Sweden founded in 1904. The company is engaged in manufacturing of medical device and services for the pharmaceutical applications.  The company operates through three business segments which include Acute Care Therapies, Surgical Workflows and Life Science. Getinge AB offers various innovative solutions for Life Science such as Life Science, Hospital and Services. The rising consumers of the medical and surgical devices in healthcare sector is corresponding the treatments of diseases and manufacturing of the pharmaceutical products raised the consumption of life Science products.

  • In July 2018, Getinge AB announced the agreement with the Brazilian Federal Public Prosecutor's Office (Ministério Público Federal). The agreement is based on the manipulation of tender procedures in Brazil.

The company has wide geographic presence in North America, South America, Europe, Asia Pacific, and Middle East & Africa. It operates through its subsidiaries such as Maquet (Germany), Datascope Corp. (U.S.), ArjoHuntleigh NV/SA (Belgium), Getinge UK Limited (U.K.), Getinge USA, Inc. (U.S.), among others.